客服熱線:+1-781-999-5354 +1-00000000000
5YR企業(yè)會(huì)員
英文名稱(chēng) | 中文名稱(chēng) | CAS號(hào) | 操作 |
AMC-01 | 化合物 T29955 | 1047978-71-1 | 詳細(xì) |
GPX4-IN-6 | GPX4 抑制劑 6 | 2922824-07-3 | 詳細(xì) |
9(S)-HOTrE | 9S-羥基-10E,12Z,15Z-十八碳三烯酸 | 89886-42-0 | 詳細(xì) |
Saccharocarcin A | Saccharocarcin A | 158475-32-2 | 詳細(xì) |
MCTR3 | MCTR3 | 1784701-63-8 | 詳細(xì) |
Docosane | 二十二烷 | 629-97-0 | 詳細(xì) |
GSK046 | VERDINEXOR | 2474876-09-8 | 詳細(xì) |
Eclitasertib | ECLITASERTIB | 2125450-76-0 | 詳細(xì) |
NF-κΒ activator 1 | 化合物NF-ΚΒ ACTIVATOR 1 | 2387524-59-4 | 詳細(xì) |
Semax acetate(80714-61-0 free base) | (S)-1-(2-((S)-1-((5S,8S,11S,14S)-11-((1H-咪唑-4-基)甲基)-5-氨基-14-芐基- 8-(2-羧乙基)-6,9,12-三氧代-2-硫雜-7,10,13-三氮雜十五烷-15-?;?吡咯烷-2-羧酰胺基)乙?;鵠吡咯烷-2-羧酸醋酸鹽 | 2828433-33-4 | 詳細(xì) |
Elsinochrome A | 痂囊腔菌素AELSINOCHROME A | 24568-67-0 | 詳細(xì) |
PCSK9 Protein, Human, Recombinant (D374Y & V474I & G670E, His) | PCSK9, HUMAN, 重組蛋白 (D374Y & V474I & G670E, HIS) | 詳細(xì) | |
SI 60 | (4-羥基苯基)(甲基)(萘-1-基甲基)锍六氟銻酸鹽 | 133152-67-7 | 詳細(xì) |
Vanillic acid glucoside | 香草酸-4-Β-D-葡萄糖苷 | 32142-31-7 | 詳細(xì) |
Trastuzumab deruxtecan | Trastuzumab Deruxtecan | 1826843-81-5 | 詳細(xì) |
Kansuinine A | 甘遂萜酯A | 57701-86-7 | 詳細(xì) |
10'-Desmethoxystreptonigrin | 10-去甲氧基鏈黑霉素 | 136803-89-9 | 詳細(xì) |
(R)-Naroparcil | 化合物T68002L | 252647-51-1 | 詳細(xì) |
25-Desacetyl Rifampicin | 25 - 乙酰- 3 - [(五) - [(4 -甲基- 1 -哌嗪基)亞胺]甲基]利福霉素 | 16783-99-6 | 詳細(xì) |
CA77.1 | 化合物CA77.1 | 2412270-22-3 | 詳細(xì) |
Shepherdin 79-87 acetate | 化合物SHEPHERDIN 79-87 ACETATE | 詳細(xì) | |
Arofylline | 阿羅茶堿 | 136145-07-8 | 詳細(xì) |
11β-HSD1-IN-12 | (S)-1-((3-氯-2-甲基苯基)磺?;?-N-環(huán)己基哌啶-3-甲酰胺 | 872506-67-7 | 詳細(xì) |
Gantofiban | GANTOFIBAN | 183547-57-1 | 詳細(xì) |
1-Palmitoyl Lysophosphatidic Acid (sodium salt) | 1-PALMITOYL-2-HYDROXY-SN-GLYCERO-3-PHOSPHATE (SODIUM SALT);16:0 LYSO PA;16:0 LPA;PA(16:0/0:0) | 17618-08-5 | 詳細(xì) |
CIA-1 (Free base) | 化合物 CIA-1 | 452087-38-6 | 詳細(xì) |
C2-8 | N-(4-BROMOPHENYL)-3-{[(4-BROMOPHENYL)AMI | 300670-16-0 | 詳細(xì) |
Olanzapine impurity L HCl | 4-氨基-2-甲基-10H-噻吩[2,3-b][1,5]苯并二氮雜卓鹽酸鹽 | 138564-60-0 | 詳細(xì) |
CAY10770 | CAY10770 | 2428734-45-4 | 詳細(xì) |
PKI 14-22 amide, myristoylated Acetate | 化合物PKI 14-22 AMIDE, MYRISTOYLATED ACETATE | 詳細(xì) | |
PF-07258669 | 化合物 PF-07258669 | 2755890-53-8 | 詳細(xì) |
(±)5(6)-EpETE methyl ester | (+/-)5(6)-EPOXY-8Z,11Z,14Z,17Z-EICOSATETRAENOIC ACID, METHYL ESTER | 127716-49-8 | 詳細(xì) |
17-hydroxy Venturicidin A | 17-羥基殺黑星菌素 A | 113204-43-6 | 詳細(xì) |
5-Aminothalidomide | 泊馬度胺雜質(zhì) | 191732-76-0 | 詳細(xì) |
FGF22-IN-1 | N'-(1H-INDOL-3-YLMETHYLENE)-2-THIOPHENECARBOHYDRAZIDE | 113143-13-8 | 詳細(xì) |
SXC 2023 | (R)-2-乙酰氨基-3-((4-甲基苯甲?;?硫基)丙酸 | 1695562-36-7 | 詳細(xì) |
DiR iodide | 'DIR' IODIDE | 詳細(xì) | |
AT-121 | AT-121 | 2099681-31-7 | 詳細(xì) |
2,3-dihydro-1H-indene-5-sulfonamide | 2,3-二氫-1H-茚-5-磺酰胺 | 35203-93-1 | 詳細(xì) |
PD-1/PD-L1-IN-9 | 化合物PD-1/PD-L1-IN-9 | 2628506-54-5 | 詳細(xì) |
Ciamexon | 腈美克松 | 75985-31-8 | 詳細(xì) |
Uridine-5'-monophosphate (sodium salt hydrate) | ((2R,3S,4R,5R)-5-(2,4-二氧代-3,4-二氫嘧啶-1(2H)-基)-3,4-二羥基四氫呋喃-2-基)甲基磷酸二鈉鹽X水合物 | 681435-27-8 | 詳細(xì) |
EM-12 | Phthalimidine, 2-(2,6-dioxopiperiden-3-yl). | 26581-81-7 | 詳細(xì) |
Rel-TREM2 agonist-2 | 化合物 T62750L | 2738485-99-7 | 詳細(xì) |
PACMA 31 | PACMA 31 | 1401089-31-3 | 詳細(xì) |
4-QUinolinecarboxamide, N-[3-[[[2-[4-(aminosulfonyl)phenyl]ethyl]amino]carbonyl]phenyl]-1,2-dihydro-2-oxo- | 4-QUINOLINECARBOXAMIDE, N-[3-[[[2-[4-(AMINOSULFONYL)PHENYL]ETHYL]AMINO]CARBONYL]PHENYL]-1,2-DIHYDRO-2-OXO- | 939760-13-1 | 詳細(xì) |
Protonstatin-1 | (Z)-5-(呋喃-2-基甲基烯)-2-硫代噻唑啉-4-酮 | 521972-99-6 | 詳細(xì) |
ATG7-IN-1 | 化合物ATG7-IN-1 | 2226229-87-2 | 詳細(xì) |
Venadaparib | Venadaparib | 1681017-83-3 | 詳細(xì) |
ANT3310 | ANT3310 | 2410688-61-6 | 詳細(xì) |
DPTN dihydrochloride | DPTN鹽酸鹽 | 325767-87-1 | 詳細(xì) |
GGACK (hydrochloride) | 詳細(xì) | ||
Scandoside | 去乙酰車(chē)葉草苷酸 | 18842-99-4 | 詳細(xì) |
Nexinhib20 | 4,4-dimethyl-1-(3-nitrophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-penten-3-one | 331949-35-0 | 詳細(xì) |
Secoisolariciresinol diglucoside | 2,3-雙(3-甲氧基-4-羥基芐基)丁烷-1,4-二醇 1,4-二葡萄糖甙 | 158932-33-3 | 詳細(xì) |
17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester | 17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester | 195503-20-9 | 詳細(xì) |
PRX-07034 hydrochloride | 5-氯-2,3-二甲氧基-Α-甲基-N-[2-(甲基磺酰基)-5-(1-哌嗪基)苯基]-苯甲胺鹽酸鹽 | 903580-39-2 | 詳細(xì) |
Aurora kinase inhibitor-2 | Aurora Kinase Inhibitor II | 331770-21-9 | 詳細(xì) |
1,2,3-Trilinoelaidoyl-rac-glycerol | 十八碳二烯酸甘油三酯(TRANS-9,12) | 5188-25-0 | 詳細(xì) |
Methyl 3,4-Dihydroxyphenylacetate | 3,4-二羥基苯乙酸甲酯 | 25379-88-8 | 詳細(xì) |
13(S)-HpOTrE(γ) | 13(S)-HPOTRE(GAMMA) | 121107-97-9 | 詳細(xì) |
(R)-Monepantel | 化合物 (R)-MONEPANTEL | 887148-70-1 | 詳細(xì) |
sbp-7455 | 化合物SBP-7455 | 1884222-74-5 | 詳細(xì) |
IMB-XMA0038 | 化合物 IMB-XMA0038 | 921812-26-2 | 詳細(xì) |
Solpecainol | 索培卡諾 | 155321-96-3 | 詳細(xì) |
Arecoline | 檳榔堿 | 63-75-2 | 詳細(xì) |
SphK1&2-IN-1 | 化合物WAY-272077 | 1415662-57-5 | 詳細(xì) |
11β-HSD1 inibitor 19 | 化合物T72022 | 946400-19-7 | 詳細(xì) |
GV-150013X | 化合物T27503L | 151386-96-8 | 詳細(xì) |
Kukoamine B mesylate | 地骨皮乙素 甲磺酸鹽 | 1375179-86-4 | 詳細(xì) |
3-(3,6-dichloro-9H-carbazol-9-yl)propanoic acid | 3-(3,6-dichloro-9H-carbazol-9-yl)propanoic acid | 300816-42-6 | 詳細(xì) |
PD 198306 | N-(CYCLOPROPYLMETHOXY)-3,4,5-TRIFLUORO-2-[(4-IODO-2-METHYLPHENYL)AMINO]-BENZAMIDE | 212631-61-3 | 詳細(xì) |
Pinolenic Acid ethyl ester | 5順,9順,12順-十八碳三烯酸乙酯 | 493015-74-0 | 詳細(xì) |
BMS-488043 | BMS 043 | 452296-83-2 | 詳細(xì) |
Dihydrosinapyl alcohol | 二氫芥子醇 | 20736-25-8 | 詳細(xì) |
CYM2503 | (9H-芴-9 - 基)甲基((S)-1(((S)-6 - (叔丁氧基羰基)氨基-1 - ((4 - 甲基-2 - 氧代-1,2 - 二氫喹啉-7 - 基)氨基)-1 - 氧代己-2 - 基)氨基)-3 - 環(huán)己基-1 - 氧代丙-2 - 基)氨基甲酸叔丁酯 | 1308833-36-4 | 詳細(xì) |
Rhod-2 (sodium salt) | 詳細(xì) | ||
GSK-3β inhibitor 10 | 化合物WAY-119064 | 1198098-03-1 | 詳細(xì) |
1,3-BUTANEDIOL | 1,3-丁二醇 | 107-88-0 | 詳細(xì) |
VT104 | 化合物VT104 | 2417718-25-1 | 詳細(xì) |
LMPTP INHIBITOR 1 hydrochloride | 化合物L(fēng)MPTP INHIBITOR 1 HYDROCHLORIDE | 2310135-38-5 | 詳細(xì) |
Pomisartan 2HCl | 泊米沙坦鹽酸鹽 | 詳細(xì) | |
1,3,6,8-Tetrahydroxynaphthalene | 化合物NAPHTHALENE-1,3,6,8-TETROL | 18512-30-6 | 詳細(xì) |
CYP2A6-IN-1 | (2-methylpropyl)({[3-(trifluoromethyl)phenyl]methyl})amine | 912291-11-3 | 詳細(xì) |
ABC34 | ABC34 | 1831135-56-8 | 詳細(xì) |
Dihydro Montelukast | 孟魯司特鈉二氫雜質(zhì) | 142147-67-9 | 詳細(xì) |
Calcifediol monohydrate | 骨化二醇一水合物 | 63283-36-3 | 詳細(xì) |
Vantictumab | 萬(wàn)替妥單抗 | 1345009-45-1 | 詳細(xì) |
Ibritumomab | Ibritumomab | 詳細(xì) | |
Tazomeline | 他唑美林 | 131987-54-7 | 詳細(xì) |
α-Conotoxin GI acetate | 化合物Α-CONOTOXIN GI ACETATE | 詳細(xì) | |
MBP MAPK Substrate acetate | 化合物MBP MAPK SUBSTRATE ACETATE | 詳細(xì) | |
NT-0796 | (R)-2-(((1,2,3,5,6,7-六氫-S-引達(dá)省-4-基)氨基甲?;?氧基)-3-(嘧啶-2-基)丙酸異丙酯 | 2272917-13-0 | 詳細(xì) |
6'-hydroxydihydrocinchonidine | (8Α,9R)-10,11-氫化奎寧-6',9-二醇 | 5962-19-6 | 詳細(xì) |
Qa-1b&B2M&Qdm (AMAPRTLLL) Monomer Protein, Mouse, MHC (His & Avi) | 詳細(xì) | ||
4-[(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]benzoic acid | 4-[(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]BENZOIC ACID | 199167-79-8 | 詳細(xì) |
Pinocembrin 7-O-[3''-O-galloyl-4'',6''-hexahydroxydiphenoyl]-β-D-glucoside | PINOCEMBRIN-7-O-(3''-GALLOYL-4'',6''-(S)-HEXAHYDROXYDIPHENOYL)-Β-D-GLUCOSE | 205370-59-8 | 詳細(xì) |
1,4-DPCA | 4-OXO-1,4-DIHYDRO-[1,10]PHENANTHROLINE-3-CARBOXYLIC ACID | 331830-20-7 | 詳細(xì) |
4-Nitrophenyl dodecanoate | 4-硝基苯基月桂酸酯 | 1956-11-2 | 詳細(xì) |
AVG-233 | 化合物 AVG-233 | 2151937-80-1 | 詳細(xì) |
產(chǎn)品總數(shù):32161 產(chǎn)品頁(yè)碼: | ||||
276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 |
商家暫時(shí)不對(duì)外公布